Insulin aspart vs insulin lispro: comparable pharmacodynamicsInsulin-aspartpharmacokineticsingentaconnectInpharma
Aspart and lispro insulin, is there any difference when used with an insulin pump treatment?Aspart and lispro insulin, is there any difference when used with an insulin pump treatment?Continuous subcutaneous insulin infusionInsulin pumpInsulin analoguesType...
Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult... Objective: The goal of this study was to compare the efficacy and safety profiles of biphasic insulin aspart 30 (30% soluble insulin as...
目前有300多个胰岛素类似物已在实验室制备出来,并且有些已进入市场.如速效的赖脯胰岛素(insulin lispro)和门冬胰岛素(insulin aspart).长效的甘精胰岛素(insulin ... 吕庆国,童南伟 - 《中国实用内科杂志》 被引量: 43发表: 2006年 胰岛素类似物对妊娠安全性的影响:系统评价和荟萃分析 目的 探讨胰岛素类似物门冬胰...
Compared to regular human insulin and NPH insulin, insulin lispro, aspart, and glulisine have faster onset of action, higher peak concentration and shorter duration of action. Below are the detailed discussions of the features and functions of insulin lispro, aspart, and glulisine. Insulin lispro...
The first human insulin analogue was insulin lispro (Eli Lilly), which was designed to replicate the sequence of lysine and proline at B28, B29 in insulin-like growth factor 1 (IGF-1) which does not self-associate. The low propensity of lispro to self-associate leads to a rapid dissocia...
A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabe... OBJECTIVE: The safety and efficacy of insulin aspart continuous subcutaneous insulin infusion (CSII) was compared with that of insulin lispro CS...
Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus. The use of short-acting insulin analogues (insulin lispro, insulin aspart, insulin glulisine) for adult, non-pregnant people with type 2 diabetes is still controversial, as re...
Multicenter Insulin Lispro Study Group. Arch Intern Med 157:1249–1255 Article CAS PubMed Google Scholar Arnolds S, Rave K, Hövelmann U, Fischer A, Sert-Langeron C, Heise T (2010) Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers. Exp ...
A randomized, 16-week, open-label, parallel design study of pediatric patients with type 1 diabetes (n=298) aged 4-18 years compared two subcutaneous infusion regimens administered via an external insulin pump: NOVOLOG (n=198) or insulin lispro (n=100). These two treatments resulted in com...